ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders

Core Viewpoint - The law firm Halper Sadeh LLC is investigating the fairness of the proposed sale of Adverum Biotechnologies, Inc. to Eli Lilly and Company for Adverum shareholders [1] Transaction Details - Under the proposed transaction, Adverum shareholders will receive $3.56 per share in cash [1] - Additionally, shareholders will receive one non-transferrable contingent value right (CVR) that could entitle them to receive up to an additional $8.91 per CVR in cash upon achieving two specific milestones [1]